ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Ohio State to study center expansion.

September 26, 2003

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

NSABP Executive Committee Drops Suit Against Pitt

February 10, 1995

Survey Finds Misconceptions About Cancer Worldwide

August 29, 2008

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002